DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Glyburide (Glyburide) - Adverse Event Reports - Hospitalization

 



Index of reports > Cases resulting in hospitalization (50)

     Hypoglycaemia (30)Oedema Peripheral (6)Mental Status Changes (5)Weight Increased (5)Asthenia (5)Hyperhidrosis (4)Ascites (4)Hypoglycaemic Coma (4)Confusional State (3)Rash (3)

Below is the selection of adverse event reports related to Glyburide that includes cases resulting in hospitalization.

 Reports 1 - 25 of 50   Next >>

Adverse event in 59 year old male receiving Glyburide

Reported by a pharmacist from United States on 2007-10-24

Patient: 59 year old male

Adverse reactions / side effects: Hypoglycaemia, Muscular Weakness, Asthenia, Fall

Adverse event resulted in: hospitalization

Suspect drug(s):
Glyburide
    Dosage: 10mg bid po
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2007-07-02
    End date: 2007-10-10

Insulin
    Dosage: 80units once sq
    Start date: 2007-01-04



Adverse event in 58 year old female receiving Glyburide

Reported by a physician from United States on 2007-10-18

Patient: 58 year old female, weighing 144.2 kg (317.3 pounds)

Adverse reactions / side effects: Weight Decreased, Drug Ineffective, Hypoglycaemia, Hepatic Failure, Headache, Hyperhidrosis, Cardiac Disorder, Herpes Zoster, Weight Increased, Blood Uric Acid Decreased, Kidney Infection, Transient Ischaemic Attack, Diabetes Mellitus Inadequate Control, Cardiac Failure Congestive, Renal Haemorrhage, Cellulitis, Nausea, Rash, Tremor, Renal Failure, Arthralgia, Diabetic Neuropathy, Swelling, Asthenia, Angiopathy, Influenza Like Illness

Adverse event resulted in: hospitalization

Suspect drug(s):
Actos
    Dosage: see image
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    End date: 2006-01-01

Actos
    Dosage: see image
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2001-01-01

Actos
    Dosage: see image
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2002-01-01

Actos
    Dosage: see image
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2006-01-01

Actos

Glyburide
    Dosage: 5 mg, 3 in 1 d, per oral
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2001-01-01

Glipizide
    Dosage: 5 mg, 3 in 1 d, per oral
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2004-01-01

Lyrica
    Dosage: per oral
    Administration route: Oral
    Indication: Diabetic Neuropathy
    Start date: 2004-01-01
    End date: 2004-01-01

Byetta
    Dosage: 5 mcg, 2 in 1 d, subcutaneous
    Indication: Type 2 Diabetes Mellitus
    Start date: 2007-07-01

Byetta
    Dosage: 5 mcg, 2 in 1 d, subcutaneous
    Indication: Weight Decreased
    Start date: 2007-07-01

Levaquin
    Dosage: 750 mg, 1 in 1 d, intravenous
    Indication: Kidney Infection
    Start date: 2007-01-01
    End date: 2007-01-01

Other drugs received by patient: Ibuprofen; Atacand (Candesartan Cilexetil) (16 Milligram); Lasix (Furosemide) (20 Milligram); Demadex; Nitrostat



Adverse event in 83 year old male receiving Glyburide

Reported by a physician from United States on 2007-10-17

Patient: 83 year old male

Adverse reactions / side effects: Hypoglycaemia

Adverse event resulted in: hospitalization

Suspect drug(s):
Januvia
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2007-07-01
    End date: 2007-07-29

Glyburide
    End date: 2007-07-29

Other drugs received by patient: Metformin



Adverse event in 73 year old female receiving Glyburide

Reported by a health professional (non-physician/pharmacist) from Germany on 2007-10-12

Patient: 73 year old female

Adverse reactions / side effects: Renal Failure, Diabetes Mellitus, Drug Ineffective, Cytolytic Hepatitis, Dehydration

Adverse event resulted in: hospitalization

Suspect drug(s):
Glucophage
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    End date: 2007-09-13

Crestor
    Administration route: Oral
    Indication: Hypercholesterolaemia
    Start date: 2006-11-01
    End date: 2007-09-14

Glyburide
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    End date: 2007-09-13

Acarbose
    Dosage: 100 mg tablet
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    End date: 2007-09-13

Amlor
    Dosage: 5 mg tablet
    Administration route: Oral
    Start date: 2004-01-01
    End date: 2007-09-13

Other drugs received by patient: Sectral; Lexomil; Imovane; Kardegic



Adverse event in 68 year old male receiving Glyburide

Reported by a pharmacist from United States on 2007-10-12

Patient: 68 year old male

Adverse reactions / side effects: Unresponsive TO Stimuli, Hypoglycaemia

Adverse event resulted in: hospitalization

Suspect drug(s):
Glyburide



Adverse event in 78 year old female receiving Glyburide

Reported by a consumer/non-health professional from France on 2007-10-05

Patient: 78 year old female

Adverse reactions / side effects: Thrombocytopenia, Epistaxis, Haematoma

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Avandia
    Dosage: 1tab per day
    Administration route: Oral
    Start date: 2003-01-01
    End date: 2007-06-30

Glyburide
    Dosage: 2500mcg per day
    Administration route: Oral
    Start date: 2003-01-01
    End date: 2007-06-30



Adverse event in female receiving Glyburide

Reported by a health professional (non-physician/pharmacist) from France on 2007-10-04

Patient: female

Adverse reactions / side effects: Cytolytic Hepatitis

Adverse event resulted in: hospitalization

Suspect drug(s):
Crestor
    Administration route: Oral
    Indication: Hypercholesterolaemia
    Start date: 2006-11-01
    End date: 2007-09-14

Glyburide
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    End date: 2007-09-13

Acarbose
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    End date: 2007-09-13

Amlor
    Administration route: Oral
    Start date: 2004-01-01
    End date: 2007-09-12

Glucophage
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    End date: 2007-09-13

Other drugs received by patient: Sectral; Lexomil; Imovane; Kardegic



Adverse event in 53 year old male receiving Glyburide

Reported by a pharmacist from United States on 2007-07-30

Patient: 53 year old male

Adverse reactions / side effects: Nausea, Hypoglycaemia, Inadequate Diet

Adverse event resulted in: hospitalization

Suspect drug(s):
PEG-Intron
    Dosage: 1500mcg qweek sq
    Indication: Hepatitis C
    Start date: 2007-07-11

Glyburide
    Dosage: 5mg bid po
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2007-02-08



Adverse event in 78 year old female receiving Glyburide

Reported by a pharmacist from Japan on 2007-07-30

Patient: 78 year old female, weighing 42.0 kg (92.4 pounds)

Adverse reactions / side effects: Drug Eruption, Oral Intake Reduced, Stomatitis, Rash Generalised, Mouth Ulceration, Rash, Oral Neoplasm, Eating Disorder, Oedema Mouth, Blood Glucose Increased, Stevens-Johnson Syndrome

Adverse event resulted in: hospitalization

Suspect drug(s):
Allopurinol
    Dosage: 100mg per day
    Administration route: Oral
    Indication: Hyperuricaemia
    Start date: 2007-05-11
    End date: 2007-06-01

Towamin
    Dosage: 50mg per day
    Administration route: Oral
    Indication: Hypertension
    End date: 2007-06-04

Diovan
    Dosage: 80mg twice per day
    Administration route: Oral
    Indication: Hypertension
    End date: 2007-06-04

Coniel
    Dosage: 4mg twice per day
    Administration route: Oral
    Indication: Hypertension
    End date: 2007-06-04

Natrix
    Dosage: 2mg per day
    Administration route: Oral
    Indication: Hypertension
    End date: 2007-06-04

Furosemide
    Dosage: 40mg per day
    Administration route: Oral
    Indication: Hypertension
    End date: 2007-06-04

Glyburide
    Dosage: 1.25mg per day
    Administration route: Oral
    Indication: Diabetes Mellitus
    End date: 2007-06-19

Tagamet
    Dosage: 200mg twice per day
    Administration route: Oral
    Indication: Gastritis
    End date: 2007-06-04

Mecobalamin
    Dosage: 500mcg twice per day
    Administration route: Oral
    Indication: Neuropathy Peripheral
    End date: 2007-06-04

Other drugs received by patient: Japanese Medication; Halcion



Adverse event in 91 year old male receiving Glyburide

Reported by a pharmacist from United States on 2007-07-19

Patient: 91 year old male

Adverse reactions / side effects: Hypoglycaemia

Adverse event resulted in: hospitalization

Suspect drug(s):
Glyburide



Adverse event in 77 year old male receiving Glyburide

Reported by a pharmacist from United States on 2007-07-13

Patient: 77 year old male

Adverse reactions / side effects: Hypoglycaemia

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Glyburide
    Dosage: 10mg bid po
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 1998-09-14
    End date: 2007-06-02

Rosiglitazone
    Dosage: 8mg every day po
    Administration route: Oral
    Start date: 2000-10-16
    End date: 2007-06-02



Adverse event in 55 year old male receiving Glyburide

Reported by a pharmacist from United States on 2007-07-12

Patient: 55 year old male

Adverse reactions / side effects: Hypoglycaemia, Mental Status Changes

Adverse event resulted in: hospitalization

Suspect drug(s):
Glyburide



Adverse event in 87 year old male receiving Glyburide

Reported by a pharmacist from United States on 2007-07-02

Patient: 87 year old male

Adverse reactions / side effects: Hypoglycaemia

Adverse event resulted in: hospitalization

Suspect drug(s):
Glyburide
    Dosage: 5mg bid po
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2006-04-24
    End date: 2007-06-05

Insulin
    Dosage: 65units every day sq



Adverse event in 76 year old female receiving Glyburide

Reported by a physician from Germany on 2007-07-02

Patient: 76 year old female, weighing 65.0 kg (143.0 pounds)

Adverse reactions / side effects: Hyperkalaemia, Hypoglycaemia, Unevaluable Event, Depression, Hypertension

Adverse event resulted in: hospitalization

Suspect drug(s):
Temodal
    Indication: Glioblastoma

Glyburide
    Indication: Diabetes Mellitus
    End date: 2007-05-29

Glucophage
    Indication: Drug USE FOR Unknown Indication
    End date: 2007-05-29

Other drugs received by patient: Cotrim DS



Adverse event in 55 year old male receiving Glyburide

Reported by a pharmacist from United States on 2007-06-20

Patient: 55 year old male

Adverse reactions / side effects: Hypoglycaemia, Mental Status Changes

Adverse event resulted in: hospitalization

Suspect drug(s):
Glyburide



Adverse event in 62 year old female receiving Glyburide

Reported by a consumer/non-health professional from United States on 2007-06-19

Patient: 62 year old female, weighing 144.2 kg (317.3 pounds)

Adverse reactions / side effects: Cardiac Failure Chronic, Hemiparesis, Rash, Hyperhidrosis, Tremor, Weight Increased, Blood Glucose Decreased, Arthralgia, Diabetic Neuropathy, Oedema Peripheral, Blood Glucose Fluctuation, Transient Ischaemic Attack, Asthenia

Adverse event resulted in: hospitalization

Suspect drug(s):
Actos
    Dosage: see image
    Administration route: Oral
    Indication: Diabetes Mellitus non-Insulin-Dependent
    Start date: 2001-01-01

Glyburide
    Dosage: 5 mg, 3 in 1 d, per oral
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2001-01-01

Glipizide
    Dosage: 5 mg, 3 in 1 d, per oral
    Administration route: Oral
    Indication: Diabetes Mellitus non-Insulin-Dependent
    Start date: 2004-01-01

Other drugs received by patient: Ibuprofen (Ibuprofen) (200 Milligram); Atacand (Candesartan Cilexetil) (16 Milligram); Lasix (Furosemide) (20 Milligram); Demadex; Nitrostat; Lyrica



Adverse event in male receiving Glyburide

Reported by a pharmacist from United States on 2007-06-18

Patient: male, weighing 115.0 kg (253.0 pounds)

Adverse reactions / side effects: Syncope, Hypoglycaemia, Condition Aggravated, Cardiac Failure Congestive, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Glyburide
    Dosage: 5mg bid (po)
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2006-02-01
    End date: 2007-02-10

Glyburide
    Dosage: 5mg bid (po)
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2007-02-10
    End date: 2007-04-29

Other drugs received by patient: Carvedilol; Furosemide; Lisinopril; Clopidogrel; Simvastatin



Adverse event in 51 year old female receiving Glyburide

Reported by a physician from United States on 2007-06-15

Patient: 51 year old female, weighing 86.8 kg (191.0 pounds)

Adverse reactions / side effects: Hypoglycaemia, Altered State of Consciousness, Hyperhidrosis

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Lantus
    Dosage: 34 u qd sc
    Indication: Diabetes Mellitus
    Start date: 2006-09-07

Lantus
    Dosage: 36 u qd sc
    Indication: Diabetes Mellitus

Avandia
    Dosage: 8 mg qd po
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2004-02-19

Avandia
    Dosage: 4 mg qd
    Start date: 2006-07-07

Metformin Hydrochloride
    Dosage: 2500 mg/day po
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2003-11-03

Glyburide
    Dosage: 5 mg bid po
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2004-02-19
    End date: 2007-01-07

Other drugs received by patient: Ambien; Atorvastatin Calcium (Lipitor); Prevacid; Fosamax; Pregablin (Lyrica); Boniva; Insulin Glargine (Apidra); Simvastatin



Adverse event in 78 year old male receiving Glyburide

Reported by a pharmacist from United States on 2007-06-11

Patient: 78 year old male, weighing 114.3 kg (251.5 pounds)

Adverse reactions / side effects: Hypoglycaemia, Mental Status Changes, Hyperhidrosis

Adverse event resulted in: hospitalization

Suspect drug(s):
Glyburide



Adverse event in 76 year old female receiving Glyburide

Reported by a physician from Germany on 2007-06-11

Patient: 76 year old female, weighing 65.0 kg (143.0 pounds)

Adverse reactions / side effects: Drug Level Below Therapeutic, Hyperkalaemia, Hypoglycaemia, Depression, Hypertension

Adverse event resulted in: hospitalization

Suspect drug(s):
Temodal
    Indication: Glioblastoma

Glyburide
    Indication: Diabetes Mellitus
    Start date: 2007-05-29

Glucophage
    Indication: Drug USE FOR Unknown Indication
    Start date: 2007-05-29

Other drugs received by patient: Cotrim Forte (Con.)



Adverse event in 60 year old male receiving Glyburide

Reported by a pharmacist from United States on 2007-06-07

Patient: 60 year old male

Adverse reactions / side effects: Confusional State, Abasia, Hypoglycaemia, Depressed Level of Consciousness, Lethargy

Adverse event resulted in: hospitalization

Suspect drug(s):
Glyburide
    Dosage: 10mg bid po
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 1999-09-03

Rosiglitazone
    Dosage: 4mg bid po
    Administration route: Oral



Adverse event in 78 year old male receiving Glyburide

Reported by a individual with unspecified qualification from Japan on 2007-05-21

Patient: 78 year old male

Adverse reactions / side effects: Speech Disorder, Pneumonia Aspiration, Cerebral Infarction, Hemiplegia

Adverse event resulted in: hospitalization

Suspect drug(s):
Actos
    Dosage: 15 mg (15 mg,1 in 1 d)
    Administration route: Oral
    Indication: Diabetes Mellitus non-Insulin-Dependent
    Start date: 2006-09-04
    End date: 2007-01-01

Blopress (Candesartan Cilexetil)
    Dosage: 8 mg (8 mg,1 in 1 d)
    Administration route: Oral
    Start date: 2000-10-27
    End date: 2007-01-01

Glyburide
    Dosage: 5 mg (2.5 mg,2 in 1 d)
    Administration route: Oral
    Start date: 2000-10-27
    End date: 2007-01-01



Adverse event in 69 year old male receiving Glyburide

Reported by a pharmacist from United States on 2007-05-07

Patient: 69 year old male, weighing 76.0 kg (167.2 pounds)

Adverse reactions / side effects: Malaise, Oedema Peripheral, Hypoglycaemia, Anaemia, Asthenia, Decreased Appetite

Adverse event resulted in: hospitalization

Suspect drug(s):
Glyburide



Adverse event in 78 year old male receiving Glyburide

Reported by a individual with unspecified qualification from Japan on 2007-05-01

Patient: 78 year old male

Adverse reactions / side effects: Dysstasia, Pneumonia Aspiration, Cerebral Infarction, Aphasia, Hemiplegia, Somnolence

Adverse event resulted in: hospitalization

Suspect drug(s):
Actos
    Dosage: 15 mg (15 mg, 1 in 1 d) per oral
    Administration route: Oral
    Indication: Diabetes Mellitus non-Insulin-Dependent
    Start date: 2006-09-04
    End date: 2007-01-01

Blopress (Candesartan Cilexetil)
    Dosage: 8 mg (8 mg, 1 in 1 d) per oral
    Administration route: Oral
    Start date: 2000-10-27
    End date: 2007-01-01

Glyburide
    Dosage: 10 mg (50mg, 2 in 1 d)
    Administration route: Oral
    Start date: 2000-10-27
    End date: 2007-01-01



Adverse event in male receiving Glyburide

Reported by a pharmacist from United States on 2007-04-27

Patient: male, weighing 119.8 kg (263.5 pounds)

Adverse reactions / side effects: Diarrhoea, Hypoglycaemia, Dehydration

Adverse event resulted in: hospitalization

Suspect drug(s):
Cipro
    Dosage: 500mg daily po
    Administration route: Oral
    Indication: Abscess Limb
    Start date: 2007-04-05
    End date: 2007-04-17

Glyburide
    Dosage: 10mg bid po
    Administration route: Oral
    Indication: Diabetes Mellitus non-Insulin-Dependent

Glyburide
    Dosage: 10mg bid po
    Administration route: Oral
    Indication: Osteomyelitis

Other drugs received by patient: Avandia



 Page 1   Next >>

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009